<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To further unravel the molecular pathogenesis of diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>), we performed high-resolution comparative genomic hybridization on lymph node biopsies from 70 patients </plain></SENT>
<SENT sid="1" pm="."><plain>With this strategy, we identified microdeletions of genes involved in the mutation mismatch repair (MMR) pathway in two samples </plain></SENT>
<SENT sid="2" pm="."><plain>The first patient presented with a homozygous deletion of MSH2-MSH6 due to duplication of an unbalanced pericentric inversion of chromosome 2 </plain></SENT>
<SENT sid="3" pm="."><plain>The other case showed a PMS2 heterozygous deletion </plain></SENT>
<SENT sid="4" pm="."><plain>PMS2 and MSH2-MSH6 abnormalities, respectively, resulted in a decrease and complete loss of gene expression </plain></SENT>
<SENT sid="5" pm="."><plain>However, unlike <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> associated with the hereditary non-<z:e sem="disease" ids="C0334108" disease_type="Neoplastic Process" abbrv="">polyposis</z:e> <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> syndrome or <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo>-related <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, no microsatellite instability was detected </plain></SENT>
<SENT sid="6" pm="."><plain>Mutational profiles revealed especially in one patient an aberrant hypermutation without a clear activation-induced <z:chebi fb="0" ids="17562">cytidine</z:chebi> deaminase signature, indicating a breakdown of the high-fidelity repair in favor of the error-prone repair pathway </plain></SENT>
<SENT sid="7" pm="."><plain>Our findings suggest that in a rare subset of patients, inactivation of the genes of the MMR pathway is likely an important step in the molecular pathogenesis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> and does not involve the same molecular mechanisms as other common <z:hpo ids='HP_0002664'>neoplasms</z:hpo> with MMR deficiency </plain></SENT>
</text></document>